Your browser doesn't support javascript.
loading
Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism.
Rothberg, Michael B; Hamilton, Aaron C; Greene, M Todd; Fox, Jacqueline; Lisheba, Oleg; Milinovich, Alex; Gautier, Thomas N; Kim, Priscilla; Kaatz, Scott; Hu, Bo.
Affiliation
  • Rothberg MB; Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, United States.
  • Hamilton AC; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, United States.
  • Greene MT; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, United States.
  • Fox J; The Michigan Hospital Medicine Safety Consortium Data Coordinating Center, Ann Arbor, Michigan, United States.
  • Lisheba O; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States.
  • Milinovich A; Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States.
  • Gautier TN; Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, United States.
  • Kim P; Enterprise Analytics eResearch Department, Cleveland Clinic, Cleveland, Ohio, United States.
  • Kaatz S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States.
  • Hu B; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States.
Thromb Haemost ; 122(7): 1231-1238, 2022 Jul.
Article in En | MEDLINE | ID: mdl-34784645
ABSTRACT

BACKGROUND:

Venous thromboembolism (VTE) prophylaxis is recommended for hospitalized medical patients at high risk for VTE. Multiple risk assessment models exist, but few have been compared in large datasets.

METHODS:

We constructed a derivation cohort using 6 years of data from 12 hospitals to identify risk factors associated with developing VTE within 14 days of admission. VTE was identified using a complex algorithm combining administrative codes and clinical data. We developed a multivariable prediction model and applied it to three validation cohorts a temporal cohort, including two additional years, a cross-validation, in which we refit the model excluding one hospital each time, applying the refitted model to the holdout hospital, and an external cohort. Performance was evaluated using the C-statistic.

RESULTS:

The derivation cohort included 155,026 patients with a 14-day VTE rate of 0.68%. The final multivariable model contained 13 patient risk factors. The model had an optimism corrected C-statistic of 0.79 and good calibration. The temporal validation cohort included 53,210 patients, with a VTE rate of 0.64%; the external cohort had 23,413 patients and a rate of 0.49%. Based on the C-statistic, the Cleveland Clinic Model (CCM) outperformed both the Padua (0.76 vs. 0.72, p = 0.002) and IMPROVE (0.68, p < 0.001) models in the temporal cohort. C-statistics for the CCM at individual hospitals ranged from 0.68 to 0.78. In the external cohort, the CCM C-statistic was similar to Padua (0.70 vs. 0.66, p = 0.17) and outperformed IMPROVE (0.59, p < 0.001).

CONCLUSION:

A new VTE risk assessment model outperformed recommended models.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Venous Thromboembolism Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Haemost Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Venous Thromboembolism Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Haemost Year: 2022 Document type: Article Affiliation country: United States